IIL announces construction of Rs 700 cr greenfield veterinary vaccine facility in Hyderabad
Hyderabad, Dec 28 (UNI)- Indian Immunologicals Limited (IIL), one of the largest producers of vaccines in Asia, on Thursday announced it has started construction of its new greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicaemia Vaccine (FMD+HS-Vac) at Genome Valley in Hyderabad.
National Dairy Development Board( NDDB) and IIL Chairman Dr. Meenesh Shah led the groundbreaking ceremony in the presence of IIL Managing Director Dr. K Anand Kumar and Deputy Managing Director Dr. Priyabrata Pattnaik.
This new unit will have a BSL3 facility for the manufacture of Drug substances and a Fill-Finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine, Hyderabad-based vaccine makers said in a release here.
The proposed facility has a capacity of 150 million doses/annum of FMD vaccine or FMD+HS vaccine each. With an investment of around INR 700 crore, the proposed facility is expected to create more than 750 direct and indirect jobs.
IIL, a subsidiary of the National Dairy Development Board (NDDB), has carved a niche space as a leading “One Health” organization, manufacturing animal and human vaccines. IIL also exports its products to more than 60 countries across the globe.
Speaking on the occasion, Dr Meenesh said, “This new vaccine manufacturing facility in Hyderabad is dedicated to the nation and will certainly aid in the eradication of Foot and Mouth Disease in our country. IIL’s ability to discover and manufacture affordable vaccines has saved the exchequer several thousand crores of rupees’.
Dr. Anand Kumar said, “We are the largest supplier of FMD vaccine to Government of India’s prestigious Livestock Health Disease Control Programme (LHDCP). We are in an exponential growth phase and expected to grow 40% this year alone.
IIL is seriously considering making additional investments in building infrastructure within India and in other emerging geographies including Africa in a manner to develop tools that will help in control and eradication of diseases,” he added.